SH2B3 and polycystic ovary syndrome: In a recent study, researchers found that the expression level of LNK, a regulator of insulin signaling pathway, was elevated in ovaries of insulin resistant PCOS patients compared with the non-PCOS group, and the overexpression of LNK in ovarian granulosa cell line inhibited insulin induced AKT activation (Fraser et al., 2012).